A clinical trial assessing INVA8002
Latest Information Update: 12 Dec 2022
At a glance
- Drugs INVA 8002 (Primary)
- Indications Inflammatory bowel diseases; Ulcerative colitis
- Focus Adverse reactions
Most Recent Events
- 12 Dec 2022 New trial record
Latest Information Update: 12 Dec 2022